Matthew Taylor
Stock Analyst at Jefferies
(2.65)
# 1,989
Out of 5,146 analysts
185
Total ratings
59.82%
Success rate
10.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Buy | $220 → $190 | $182.49 | +4.12% | 5 | Feb 10, 2026 | |
| PEN Penumbra | Downgrades: Hold | $335 → $374 | $339.59 | +10.13% | 2 | Jan 16, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $84.05 | +24.93% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $245.25 | +44.75% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $82.40 | +18.93% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $13.23 | +43.61% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $114.58 | +26.55% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $13.98 | +7.30% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $96.75 | -21.45% | 17 | May 24, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $125 | $1.36 | +9,091.18% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $107 → $121 | $175.35 | -31.00% | 9 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.12 | +239.81% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $26.90 | +67.29% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $8.23 | +21.51% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $11.53 | +359.67% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $13.47 | +78.17% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $381.33 | -9.53% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $99.87 | +30.17% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $15.29 | +30.80% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $46.06 | +84.54% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $91.88 | -18.37% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $251.63 | -2.63% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $20.63 | +200.53% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $112.12 | +87.30% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $13.93 | -13.85% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $73.09 | +71.02% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $75.15 | -33.47% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $494.02 | -57.49% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $69.05 | +39.03% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $2.95 | +137.29% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $11.43 | +39.98% | 2 | Jul 19, 2017 |
Becton, Dickinson and Company
Feb 10, 2026
Maintains: Buy
Price Target: $220 → $190
Current: $182.49
Upside: +4.12%
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $335 → $374
Current: $339.59
Upside: +10.13%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $84.05
Upside: +24.93%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $245.25
Upside: +44.75%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $82.40
Upside: +18.93%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $13.23
Upside: +43.61%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $114.58
Upside: +26.55%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $13.98
Upside: +7.30%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $96.75
Upside: -21.45%
Allurion Technologies
Feb 9, 2024
Initiates: Buy
Price Target: $125
Current: $1.36
Upside: +9,091.18%
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $175.35
Upside: -31.00%
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $4.12
Upside: +239.81%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $26.90
Upside: +67.29%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $8.23
Upside: +21.51%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $11.53
Upside: +359.67%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $13.47
Upside: +78.17%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $381.33
Upside: -9.53%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $99.87
Upside: +30.17%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $15.29
Upside: +30.80%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $46.06
Upside: +84.54%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $91.88
Upside: -18.37%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $251.63
Upside: -2.63%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $20.63
Upside: +200.53%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $112.12
Upside: +87.30%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $13.93
Upside: -13.85%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $73.09
Upside: +71.02%
Oct 12, 2022
Initiates: Buy
Price Target: $50
Current: $75.15
Upside: -33.47%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $494.02
Upside: -57.49%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $69.05
Upside: +39.03%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $2.95
Upside: +137.29%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $11.43
Upside: +39.98%